A Supersaturated Oxygen Emulsion for Wound Care... (2020 study) Skip to main content
Clinical Study Journal of drugs in dermatology : JDD 2020

A Supersaturated Oxygen Emulsion for Wound Care and Skin Rejuvenation.

Gold MH, Nestor MS, Journal of drugs in dermatology : JDD, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote a review describing how oxygen relates to wound healing and a topical oxygen-carrying skin product made for use after aesthetic skin procedures.

What They Found

This review article describes a topical perfluorocarbon emulsion, made of perfluorodecalin, water, plant-derived emulsifiers and a preservative, that is designed for use in dermatology, and the abstract reports no patient results for it. The abstract states that wounds are often low in oxygen and that the outer layers of skin get their oxygen almost entirely from the air. It says perfluorocarbon preparations containing 2% of these compounds can absorb up to seven times more oxygen than water at 37 degrees C, which it gives as a general property of such preparations and not as a measurement of this product. The product is designed to be applied 2 to 4 times daily after skin rejuvenation procedures, and the abstract says it reduces the incidence of post-procedure complications, without giving numbers.

What This Means for Canadian Patients

The abstract says hyperbaric oxygen therapy is beneficial for treating nonhealing wounds such as diabetic ulcers and has been used to speed recovery after aesthetic procedures, but it is not suitable for home use. The topical emulsion is described as well suited to patient application after energy-based aesthetic procedures. The abstract reports no trial data on the emulsion, so it does not show how well the product works for any individual patient.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract gives no sample size, comparison group or measured results for the emulsion, so its claim of fewer post-procedure complications cannot be checked from the abstract alone.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 32550688
Year Published 2020
Journal Journal of drugs in dermatology : JDD
MeSH Terms Administration, Cutaneous; Emulsions; Humans; Hyperbaric Oxygenation; Rejuvenation; Skin; Wound Healing; Wounds, Penetrating

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology